CHINA-HI-TECH-FAIR
10.11.2020 16:10:05 CET | Business Wire | Press release
Themed "Transforming Future with Technology, Driving Development with Innovation", the 22nd China High-Tech Fair (CHTF2020) will open on November 11-15, 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201110005830/en/
As the trend-setter of the hi-tech industry, CHTF will provide a glimpse of the future technologies with its “3 Highlights” and “5 Trends”.
Highlight 1: "13th Five-Year" technological achievements
State-level exhibitors including the Ministry of Commerce, the Ministry of Science and Technology, the State Intellectual Property Office, the Chinese Academy of Sciences, and the Ministry of Industry and Information Technology will display technology-related achievements of China’s 13th Five-Year Plan.
Highlight 2: Online show to facilitate overseas exhibitors
Despite the COVID-19 pandemic, 41 countries and international organizations have confirmed to participate in the offline fair, including Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Czech Republic, and Germany. For those who cannot come in person, the “Belt and Road” and International Pavilions will provide online exhibition opportunities.
Highlight 3: Multiple activities to integrate industries, universities and research institutions
CHTF2020 will gather domestic and foreign leading enterprises, technology SMEs, MAKERS, financing institutions, as well as global government officials, entrepreneurs, economists and scholars to discuss policies and make academic exchanges.
Trend 1: AI entering daily life
CHTF2020 will witness more companies embracing "AI + industry". Huawei will bring full-stack, full-scenario solutions and provide development platforms for the governments and enterprises. With a new set of algorithm ecology, channel ecology, and manufacturing ecology, major high-tech companies are making AI technology available to everyone.
Trend 2: Emerging anti-epidemic technologies
CHTF2020 will display new anti-epidemic technologies and products, and their latest applications.
Trend 3: Commercial deployment of 5G
Commercial 5G applications, including 5G smart poles, 5G micro-stations, 5G smart home, and 5G telemedicine will be showcased on the Information Technology and Products Exhibition at Hall 1.
Trend 4: Cutting-edge technologies
About 50 institutes will exhibit at the Pavilion of the Chinese Academy of Sciences.
Trend 5: Smart city
The CHTF Smart City Exhibition will showcase Smart City Ecological Construction, AI Application, 5G, Cloud Computing and Big Data, IoT, Mobile Application and Smart Hardware. Asia-Pacific Smart City Development Summit will also be held.
For more: http://www.chtf.com/english/
View source version on businesswire.com: https://www.businesswire.com/news/home/20201110005830/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom